<DOC>
	<DOCNO>NCT01041183</DOCNO>
	<brief_summary>Patients undergo general anesthesia laparoscopic cholecystectomy high risk postoperative nausea vomiting ( PONV ) . The investigator investigate effect oral IV ramosetron PONV prophylaxis laparoscopic cholecystectomy .</brief_summary>
	<brief_title>The Effect Oral Intravenous Ramosetron During Laparoscopic Cholecystectomy</brief_title>
	<detailed_description />
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Ramosetron</mesh_term>
	<criteria>ASA III patient , 2565 year , electivelaparoscopic cholecystectomy general anesthesia GI disease , pregnant menstruating , history motion sickness and/or postoperative emesis , antiemetic within 24 h surgery</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Oral plus IV ramosetron may effective</keyword>
	<keyword>IV ramosetron oral ramosetron prophylaxis</keyword>
	<keyword>PONV laparoscopic cholecystectomy</keyword>
</DOC>